COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03300505
Recruitment Status : Suspended (Enrollment and/or interactions/interventions temporarily paused due to COVID-19 and expected to resume in the future. This is not a suspension of IRB approval.)
First Posted : October 3, 2017
Last Update Posted : May 1, 2020
Information provided by (Responsible Party):
University of Michigan Rogel Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : May 2024
Estimated Study Completion Date : May 2024